ETROLIZUMAB
UNII I2A72G2V3J

Substance Identification & Data

This profile provides standardized clinical and technical data for Etrolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I2A72G2V3J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1044758-60-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

I2A72G2V3J

CAS Registry Number

1044758-60-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ETROLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C97944

National Cancer Institute reference terminology for clinical and research data.

INN ID

9290

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-80

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Etrolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ETROLIZUMAB

Common Names & Synonyms

ANTI-.BETA.7

ETROLIZUMAB [INN]

ETROLIZUMAB [USAN]

ETROLIZUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.4.BETA.7/INTEGRIN .ALPHA.E.BETA.7) (HUMAN-RAT MONOCLONAL RHUMAB BETA7 HEAVY CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL RHUMAB BETA7 LIGHT CHAIN, DIMER